Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria

ClinicalTrials.gov ID: NCT03847090

Public ClinicalTrials.gov record NCT03847090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients With Enteric Hyperoxaluria: A Phase III Randomized, Double-Blind, Placebo-Controlled Study (URIROX-2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy, durability and long-term safety of reloxaliase in patients with enteric hyperoxaluria.

Study identification

NCT ID
NCT03847090
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allena Pharmaceuticals
Industry
Enrollment
92 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 26, 2019 (Actual)
Primary completion
May 19, 2022 (Actual)
Completion
May 19, 2022 (Actual)
Last update posted
Jun 10, 2022

2019 – 2022

United States locations

U.S. sites
64
U.S. states
30
U.S. cities
60
Facility City State ZIP Site status
University of Alabama- Department of Urology Birmingham Alabama 35234 —
Alliance for Multispecialty Research, LLC Mobile Alabama 36608 —
Aventiv Research Inc. Mesa Arizona 85210 —
Arizona Kidney Disease and Hypertension Center (AKDHC)- Phoenix Peoria Arizona 85381 —
Arizona Kidney Disease and Hypertension Center (AKDHC)- Glendale Phoenix Arizona 85016 —
Mayo Mercy Hospital Phoenix Arizona 85054 —
Urological Associates of Southern Arizona Tucson Arizona 85715 —
Banner University Medical Center Tucson Arizona 85724 —
Arkansas Urology Little Rock Arkansas 72211 —
Applied Research Center of Arkansas Little Rock Arkansas 72212 —
Renal Consultants Medical Group Granada Hills California 91344 —
Amicis Research Northridge California 91324 —
University of California, San Diego (UCSD) Health System San Diego California 92103 —
University of California- San Francisco (UCSF) San Francisco California 94143 —
Stanford University School of Medicine Stanford California 94305 —
Sutter Health- Sacramento Vacaville California 95688 —
Yale University School of Medicine New Haven Connecticut 06510 —
South Florida Nephrology Group PA Research Div Coral Springs Florida 33071 —
University of Florida College of Medicine Gainesville Florida 32610 —
Quantum Clinical Research Hialeah Florida 33012 —
Mayo Clinic Jacksonville Florida 32224 —
Pro-Care Research Center, Corp Miami Gardens Florida 33014 —
Avanza Medical Research Center Pensacola Florida 32503 —
University of South Florida Tampa Florida 33606 —
Idaho Catalyst Clinical Research Idaho Falls Idaho 83404 —
Idaho Urologic Institute Meridian Idaho 83642 —
IU Health Physicians Carmel Indiana 46032 —
Indiana University (IU) Nephrology Indianapolis Indiana 46202 —
University of Iowa Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
University of Kentucky Lexington Kentucky 40536 —
Regional Urology Shreveport Louisiana 71106 —
Chesapeake Urology Associates, LLC d/b/a/ Chesapeake Urology Research Associates Glen Burnie Maryland 21061 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48084 —
Mayo Clinic- Department of Nephrology Hyperoxaluria Center Rochester Minnesota 55905 —
University of Missouri Healthcare Columbia Missouri 65211 —
Montana Medical Research, Inc Missoula Montana 59808 —
Sheldon J. Freedman, MD Las Vegas Nevada 89144 —
New York Presbyterian/Queens Flushing New York 11355 —
Long Island Gastrointestinal Research Group Great Neck New York 11023 —
New York University School of Medicine- Langone Medical Center New York New York 10016 —
University of Rochester Rochester New York 14620 —
University of North Carolina (UNC) - Chapel Hill Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27516 —
Associated Urologists of North Carolina Raleigh North Carolina 27612 —
University of Cincinnati (UC) - Department of Nephrologyv Cincinnati Ohio 45267 —
Ohio State University (OSU)-Renal Division Columbus Ohio 43210 —
Clinical Research Solutions- Middleburg Heights Middleburg Heights Ohio 44130 —
Genito-Urinary Surgeons Toledo Ohio 43606 —
Oregon Health and Science University (OHSU) Portland Oregon 97239 —
Northeast Clinical Research Center Bethlehem Pennsylvania 18017 —
Lifespan Physician Group Minimally Invasive Urology Institute Providence Rhode Island 02916 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Vanderbilt University Medical Center Nashville Tennessee 37212 —
Accelemed Research Institute Austin Texas 78745 —
Renal Disease Research Institute Dallas Texas 75246 —
Houston Metro Urology Houston Texas 77027 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900 —
Urology San Antonio Research San Antonio Texas 78229 —
Baylor Scott and White Research Institute- Temple Temple Texas 76508 —
Virginia Urology Richmond Virginia 23235 —
Urology of Virginia Virginia Beach Virginia 23462 —
University of Wisconsin - Division of Nephrology Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03847090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03847090 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →